Eli Lilly said on Tuesday its diabetes drug tirzepatide has received approval from Chinese regulators, setting up ...

China gave the greenlight to Eli Lilly & Co.’s blockbuster drug tirzepatide for use in treating diabetes, a move that will ...

In general, men tend to develop Type 2 diabetes at a lower BMI than women and at younger ages. They also are more likely to ...

Expert opinion from Jodie Bennett BSC. Food Science and Nutrition · 6 years of experience · UK There has indeed has been a ...

Though Mason Miller grew up a loyal Pirates fan in Pittsburgh, Albert Pujols took precedence as his favorite player. Yes, ...

Injected medications that treat diabetes and obesity increase the risk of a rare but serious side effect: stomach paralysis, ...

While it may seem like everyone is taking Ozempic, not everyone can afford to. The high price of popular diabetes drugs ...

AdventHealth researchers are seeking participants for a study that will attempt to identify people with type 1 diabetes early ...

HealthToday, a pioneering platform dedicated to fostering holistic health and wellness, is thrilled to announce the release ...

Eli Lilly (NYSE:LLY) has secured China approval for its blockbuster drug tirzepatide for use in treating diabetes.

Eli Lilly and Company announced on Tuesday that the National Medical Products Administration (NMPA) in China has approved the ...